Literature DB >> 17469812

Characterization and optimization of selective, nonpeptidic inhibitors of cathepsin S with an unprecedented binding mode.

Hiroaki Inagaki1, Hiroyuki Tsuruoka, Michael Hornsby, Scott A Lesley, Glen Spraggon, Jonathan A Ellman.   

Abstract

The substrate activity screening (SAS) method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain a novel (2-arylphenoxy)acetaldehyde inhibitor, 2, with a 0.49 microM Ki value (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527). In this paper we disclose the X-ray structure of a complex between cathepsin S and inhibitor 2 which reveals an unprecedented binding mode. On the basis of this structure, additional 2-biaryloxy substrates with greatly increased cleavage efficiency were designed. Conversion of the optimized substrates to the corresponding aldehyde inhibitors yielded a low molecular weight (304 Daltons) and potent (9.6 nM) cathepsin S inhibitor that showed from 100- to >1000-fold selectivity relative to cathepsins B, L, and K.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17469812     DOI: 10.1021/jm070111+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models.

Authors:  Melissa J Leyva; Francesco Degiacomo; Linda S Kaltenbach; Jennifer Holcomb; Ningzhe Zhang; Juliette Gafni; Hyunsun Park; Donald C Lo; Guy S Salvesen; Lisa M Ellerby; Jonathan A Ellman
Journal:  Chem Biol       Date:  2010-11-24

Review 2.  Using specificity to strategically target proteases.

Authors:  Mark D Lim; Charles S Craik
Journal:  Bioorg Med Chem       Date:  2008-03-30       Impact factor: 3.641

3.  Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

Authors:  Katherine A Rawls; P Therese Lang; Jun Takeuchi; Shinichi Imamura; Tyler D Baguley; Christoph Grundner; Tom Alber; Jonathan A Ellman
Journal:  Bioorg Med Chem Lett       Date:  2009-10-25       Impact factor: 2.823

4.  Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.

Authors:  Medhanit Bahta; George T Lountos; Beverly Dyas; Sung-Eun Kim; Robert G Ulrich; David S Waugh; Terrence R Burke
Journal:  J Med Chem       Date:  2011-03-28       Impact factor: 7.446

5.  Identification of multiple structurally distinct, nonpeptidic small molecule inhibitors of protein arginine deiminase 3 using a substrate-based fragment method.

Authors:  Haya Jamali; Hasan A Khan; Joseph R Stringer; Somenath Chowdhury; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2015-03-05       Impact factor: 15.419

Review 6.  Emerging principles in protease-based drug discovery.

Authors:  Marcin Drag; Guy S Salvesen
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

7.  Asymmetric synthesis of amines using tert-butanesulfinamide.

Authors:  Hai-Chao Xu; Somenath Chowdhury; Jonathan A Ellman
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

8.  Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes.

Authors:  Edgar Deu; Melissa J Leyva; Victoria E Albrow; Mark J Rice; Jonathan A Ellman; Matthew Bogyo
Journal:  Chem Biol       Date:  2010-08-27

9.  Identification of a new class of nonpeptidic inhibitors of cruzain.

Authors:  Katrien Brak; Patricia S Doyle; James H McKerrow; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2008-04-25       Impact factor: 15.419

10.  Asymmetric synthesis of propargylamines as amino acid surrogates in peptidomimetics.

Authors:  Matthias Wünsch; David Schröder; Tanja Fröhr; Lisa Teichmann; Sebastian Hedwig; Nils Janson; Clara Belu; Jasmin Simon; Shari Heidemeyer; Philipp Holtkamp; Jens Rudlof; Lennard Klemme; Alessa Hinzmann; Beate Neumann; Hans-Georg Stammler; Norbert Sewald
Journal:  Beilstein J Org Chem       Date:  2017-11-15       Impact factor: 2.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.